Extreme hypocalcaemia and hyperparathyroidism following denosumab. Is this drug safe in chronic kidney disease?

Nefrologia. 2014;34(4):542-4. doi: 10.3265/Nefrologia.pre2014.Mar.12383.
[Article in English, Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Bone Density Conservation Agents / adverse effects*
  • Contraindications
  • Denosumab / adverse effects*
  • Female
  • Humans
  • Hyperparathyroidism / chemically induced*
  • Hypocalcemia / chemically induced*
  • Renal Insufficiency, Chronic / complications*
  • Severity of Illness Index

Substances

  • Bone Density Conservation Agents
  • Denosumab